Skip to Content
Merck
CN

700150

(S)-Boc-5-oxopyrrolidine-2-carboxylic acid

97%

Synonym(s):

(−)-1-Boc-L-pyroglutamic acid, Boc-pyr-OH

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C10H15NO5
CAS Number:
53100-44-0
Molecular Weight:
229.23
NACRES:
NA.22
PubChem Substance ID:
329762185
UNSPSC Code:
12352106
EC Number:
258-362-2
MDL number:
MFCD00672316

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

(S)-Boc-5-oxopyrrolidine-2-carboxylic acid, 97%

InChI key

MJLQPFJGZTYCMH-LURJTMIESA-N

InChI

1S/C10H15NO5/c1-10(2,3)16-9(15)11-6(8(13)14)4-5-7(11)12/h6H,4-5H2,1-3H3,(H,13,14)/t6-/m0/s1

SMILES string

CC(C)(C)OC(=O)N1[C@@H](CCC1=O)C(O)=O

assay

97%

form

powder

optical activity

[α]22/D −35.0, c = 1 in chloroform

reaction suitability

reaction type: Boc solid-phase peptide synthesis

mp

118-123 °C (dec.)

application(s)

peptide synthesis

storage temp.

−20°C

Quality Level

100

Related Categories

pictograms

Exclamation mark
GHS07

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKCX9597
MKCL8554
MKBQ1453V
MKBW6125V
MKBT7023V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Kathrin Gnoth et al.
Alzheimer's research & therapy, 12(1), 149-149 (2020-11-16)
Amyloid β (Aβ)-directed immunotherapy has shown promising results in preclinical and early clinical Alzheimer's disease (AD) trials, but successful translation to late clinics has failed so far. Compelling evidence suggests that post-translationally modified Aβ peptides might play a decisive role
Qiuyu Gong et al.
Advanced science (Weinheim, Baden-Wurttemberg, Germany), 5(4), 1700664-1700664 (2018-05-04)
Previous study showed that pyroglutamate aminopeptidase 1 (PGP-1) has a relationship with the immune response in cells. However, whether PGP-1 is involved in inflammatory response in vivo and can serve as a new inflammatory cytokine are still unclear. To address

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service